PT1294358E
(en)
|
2000-06-28 |
2004-12-31 |
Smithkline Beecham Plc |
MOORING PROCESS BY HUMIDITY
|
AU2002246864A1
(en)
|
2000-12-27 |
2002-07-24 |
The Trustees Of Columbia University In The City Of New York |
Pim kinase-related methods
|
DE10123055A1
(en)
|
2001-05-11 |
2003-03-20 |
Gruenenthal Gmbh |
Screening method with PIM1-Kinase or PIM3-Kinase
|
DE10226702A1
(en)
|
2002-06-14 |
2004-09-09 |
Grünenthal GmbH |
Antisense oligonucleotides against PIM1
|
EP1558751A4
(en)
|
2002-09-16 |
2007-08-22 |
Plexxikon Inc |
Crystal structure of pim-1 kinase
|
WO2006078228A1
(en)
|
2002-09-16 |
2006-07-27 |
Plexxikon, Inc. |
Methods for the design of molecular scaffolds and ligands
|
CL2003002287A1
(en)
|
2002-11-25 |
2005-01-14 |
Wyeth Corp |
COMPOUNDS DERIVED FROM TIENO [3,2-b] -PIRIDINA-6-CARBONITRILOS AND TIENEO [2,3-b] -PIRIDINA-5-CARBONITRILS, PHARMACEUTICAL COMPOSITION, PROCEDURE OF PREPARATION AND INTERMEDIARY COMPOUNDS, AND THEIR USE IN THE TREATMENT OF CANCER, APOPLEJIA, OSTEOPOROSIS
|
WO2004090106A2
(en)
|
2003-04-04 |
2004-10-21 |
Vertex Pharmaceuticals Incorporated |
Crystal structures of human pim-1 kinase protein complexes and binding pockets thereof, and uses thereof in drug design
|
US20050164300A1
(en)
|
2003-09-15 |
2005-07-28 |
Plexxikon, Inc. |
Molecular scaffolds for kinase ligand development
|
WO2005033310A1
(en)
|
2003-10-01 |
2005-04-14 |
Grünenthal GmbH |
Pim-1 specific dsrna compounds
|
WO2006006569A1
(en)
|
2004-07-12 |
2006-01-19 |
Nihon Nohyaku Co., Ltd. |
Phenylpyridine derivative or salt thereof, herbicide containing the same as active ingredient, and method of use thereof
|
KR101328273B1
(en)
|
2004-12-28 |
2013-11-14 |
키넥스 파마슈티컬즈, 엘엘씨 |
Compositions and methods of treating cell proliferation disorders
|
PE20070100A1
(en)
|
2005-06-22 |
2007-03-10 |
Plexxikon Inc |
PIRROLO [2,3-b] PYRIDINE DERIVATIVES AS KINE MODULATORS
|
WO2007011760A2
(en)
|
2005-07-15 |
2007-01-25 |
Kalypsys, Inc. |
Inhibitors of mitotic kinesin
|
EP1931676B1
(en)
|
2005-10-06 |
2011-11-16 |
Schering Corporation |
Pyrazolopyrimidines as protein kinase inhibitors
|
EP1940792B1
(en)
|
2005-10-06 |
2014-06-04 |
Exelixis, Inc. |
Aminopyrimidine, aminopyridine and aniline derivatives as inhibitors of pim-1 and/or pim-3
|
ATE517874T1
(en)
|
2005-10-21 |
2011-08-15 |
Exelixis Inc |
PYRIMIDINONES AS MODULATORS OF CASEINKINASE II (CK2)
|
WO2007052843A1
(en)
|
2005-11-04 |
2007-05-10 |
Takeda Pharmaceutical Company Limited |
Heterocyclic amide compound and use thereof
|
WO2007084857A2
(en)
|
2006-01-13 |
2007-07-26 |
President And Fellows Of Harvard College |
Methods and compositions for treating cell proliferative disorders
|
US20090253156A1
(en)
|
2006-05-05 |
2009-10-08 |
Perkinelmer Las, Inc. |
Mass spectrometry methods for multiplexed quantification of protein kinases and phosphatases
|
AU2007265373B2
(en)
|
2006-06-29 |
2013-02-21 |
Atnx Spv, Llc |
Biaryl compositions and methods for modulating a kinase cascade
|
DK2041071T3
(en)
|
2006-06-29 |
2014-09-01 |
Kinex Pharmaceuticals Llc |
BIARLYL COMPOSITIONS AND PROCEDURES FOR MODULATING A CHINA CASE
|
EP2061762B1
(en)
|
2006-08-16 |
2011-07-27 |
Boehringer Ingelheim International GmbH |
Pyrazine compounds, their use and methods of preparation
|
WO2008045252A2
(en)
|
2006-10-04 |
2008-04-17 |
The Board Of Trustees Of The Leland Stanford Junior University |
Engineered integrin binding peptides
|
CA2668255A1
(en)
|
2006-10-31 |
2008-05-08 |
Schering Corporation |
Anilinopiperazine derivatives and methods of use thereof
|
MY146474A
(en)
|
2006-11-06 |
2012-08-15 |
Supergen Inc |
Imidazo[1,2-b]pyridazine and pyrazolo[1,5-a]pyrimidine derivatives and their use as protein kinase inhibitors
|
WO2008082840A1
(en)
|
2006-12-29 |
2008-07-10 |
Abbott Laboratories |
Pim kinase inhibitors as cancer chemotherapeutics
|
WO2008082839A2
(en)
|
2006-12-29 |
2008-07-10 |
Abbott Laboratories |
Pim kinase inhibitors as cancer chemotherapeutics
|
JP5330274B2
(en)
|
2007-03-01 |
2013-10-30 |
ノバルティス アーゲー |
PIM kinase inhibitor and method of use thereof
|
US20100144751A1
(en)
|
2007-03-28 |
2010-06-10 |
Array Biopharma Inc. |
IMIDAZO[1,2-a]PYRIDINE COMPOUNDS AS RECEPTOR TYROSINE KINASE INHIBITORS
|
KR101538179B1
(en)
|
2007-04-03 |
2015-07-20 |
어레이 바이오파마 인크. |
Imidazo[1,2-a]pyridine compounds as receptor tyrosine kinase inhibitors
|
WO2008143759A1
(en)
|
2007-04-25 |
2008-11-27 |
Exelixis, Inc. |
Pyrimidinones as casein kinase ii (ck2) modulators
|
WO2008133955A1
(en)
|
2007-04-25 |
2008-11-06 |
Exelixis, Inc. |
6-phenylpyrimidinones as pim modulators
|
RU2474580C2
(en)
|
2007-07-19 |
2013-02-10 |
Шеринг Корпорейшн |
Heterocyclic amide compounds as protein kinase inhibitors
|
KR20100042287A
(en)
|
2007-07-31 |
2010-04-23 |
쉐링 코포레이션 |
Anti-mitotic agent and aurora kinase inhibitor combination as anti-cancer treatment
|
US20110263664A1
(en)
|
2007-11-15 |
2011-10-27 |
Musc Foundation For Research Development |
Inhibitors of PIM-1 Protein Kinases, Compositions and Methods for Treating Prostate Cancer
|
CA2705862C
(en)
|
2007-11-16 |
2018-03-27 |
San Diego State University Research Foundation |
Compositions and method for manipulating pim-1 activity in circulatory system cells
|
CA2716755A1
(en)
|
2008-02-29 |
2009-09-03 |
Peter C. Chua |
Protein kinase modulators
|
AR070531A1
(en)
*
|
2008-03-03 |
2010-04-14 |
Novartis Ag |
PIM KINASE INHIBITORS AND METHODS FOR USE
|
US8168794B2
(en)
|
2008-03-03 |
2012-05-01 |
Novartis Ag |
Pim kinase inhibitors and methods of their use
|
JP2011519972A
(en)
|
2008-05-12 |
2011-07-14 |
アムネスティックス・インコーポレーテッド |
Compounds for RHO kinase inhibition and for improving learning and memory
|
MX2011000150A
(en)
|
2008-06-30 |
2011-04-05 |
Cylene Pharmaceuticals Inc |
Oxindole compounds.
|
TWI461423B
(en)
|
2008-07-02 |
2014-11-21 |
Astrazeneca Ab |
Thiazolidinedione compounds useful in the treatment of pim kinase related conditions and diseases
|
FR2933409B1
(en)
|
2008-07-03 |
2010-08-27 |
Centre Nat Rech Scient |
NEW PYRROLO ° 2,3-a! CARBAZOLES AND THEIR USE AS INHIBITORS OF PIM KINASES
|
TWI496779B
(en)
|
2008-08-19 |
2015-08-21 |
Array Biopharma Inc |
Triazolopyridine compounds as pim kinase inhibitors
|
WO2010022081A1
(en)
|
2008-08-19 |
2010-02-25 |
Array Biopharma Inc. |
Triazolopyridine compounds as pim kinase inhibitors
|
JP5584215B2
(en)
|
2008-09-02 |
2014-09-03 |
ノバルティス アーゲー |
Heterocyclic PIM kinase inhibitor
|
AU2009289316A1
(en)
|
2008-09-02 |
2010-03-11 |
Novartis Ag |
Bicyclic kinase inhibitors
|
GEP20135849B
(en)
|
2008-09-02 |
2013-06-10 |
Novartis Ag |
Picolinamide derivatives as kinase inhibitors
|
PT2350071E
(en)
|
2008-10-22 |
2014-04-11 |
Array Biopharma Inc |
Substituted pyrazolo[1,5-a]pyrimidine compounds as trk kinase inhibitors
|
GB0821307D0
(en)
|
2008-11-21 |
2008-12-31 |
Summit Corp Plc |
Compounds for treatment of duchenne muscular dystrophy
|
AR074830A1
(en)
|
2008-12-19 |
2011-02-16 |
Cephalon Inc |
PIRROLOTRIAZINAS AS ALK AND JAK2 INHIBITORS
|
WO2010135401A2
(en)
|
2009-05-19 |
2010-11-25 |
San Diego State University Foundation |
Kinase-mediated cytoprotection and enhanced cellular engraftment and persistence
|
CA2762313A1
(en)
|
2009-05-20 |
2010-11-25 |
Cylene Pharmaceuticals, Inc. |
Pyrazolopyrimidines and related heterocycles as kinase inhibitors
|
US20100298302A1
(en)
|
2009-05-20 |
2010-11-25 |
Fabrice Pierre |
Novel protein kinase modulators
|
AU2010249380B2
(en)
|
2009-05-22 |
2015-08-20 |
Incyte Holdings Corporation |
N-(hetero)aryl-pyrrolidine derivatives of pyrazol-4-yl-pyrrolo[2,3-d]pyrimidines and pyrrol-3-yl-pyrrolo[2,3-d]pyrimidines as Janus kinase inhibitors
|
US20100331315A1
(en)
|
2009-06-18 |
2010-12-30 |
Mustapha Haddach |
Rhodanines and related heterocycles as kinase inhibitors
|
PL2448938T3
(en)
|
2009-06-29 |
2014-11-28 |
Incyte Holdings Corp |
Pyrimidinones as pi3k inhibitors
|
US20110065698A1
(en)
|
2009-08-26 |
2011-03-17 |
Cylene Pharmaceuticals, Inc. |
Novel protein kinase modulators
|
AR078012A1
(en)
|
2009-09-01 |
2011-10-05 |
Incyte Corp |
HETEROCICLIC DERIVATIVES OF PIRAZOL-4-IL-PIRROLO (2,3-D) PYRIMIDINS AS INHIBITORS OF THE QUANASA JANUS
|
SG10201405568UA
(en)
|
2009-09-08 |
2014-11-27 |
Hoffmann La Roche |
4-substituted pyridin-3-yl-carboxamide compounds and methods of use
|
US8435976B2
(en)
|
2009-09-08 |
2013-05-07 |
F. Hoffmann-La Roche |
4-substituted pyridin-3-yl-carboxamide compounds and methods of use
|
AU2010292116A1
(en)
|
2009-09-11 |
2012-05-03 |
Cylene Pharmaceuticals Inc. |
Pharmaceutically useful heterocycle-substituted lactams
|
WO2011035022A1
(en)
|
2009-09-16 |
2011-03-24 |
Cylene Pharmaceuticals, Inc. |
Tricyclic compounds and pharmaceutical uses thereof
|
CA2774266A1
(en)
|
2009-09-16 |
2011-03-24 |
Cylene Pharmaceuticals, Inc. |
Novel tricyclic protein kinase modulators
|
JP5993742B2
(en)
|
2009-10-29 |
2016-09-14 |
ジェノスコ |
Kinase inhibitor
|
EP2332917B1
(en)
|
2009-11-11 |
2012-08-01 |
Sygnis Bioscience GmbH & Co. KG |
Compounds for PIM kinase inhibition and for treating malignancy
|
CA2780031A1
(en)
|
2009-11-12 |
2011-05-19 |
Selvita S.A. |
A compound, a process for its preparation, a pharmaceutical composition, use of a compound, a method for modulating or regulating serine/threonine kinases and a serine/threonine kinases modulating agent
|
MX2012005332A
(en)
|
2009-11-13 |
2012-10-15 |
Oscotec Inc |
Kinase inhibitors.
|
WO2011063398A1
(en)
|
2009-11-23 |
2011-05-26 |
Cylene Pharamaceuticals, Inc. |
Polymorphs and salts of a kinase inhibitor
|
RU2607453C2
(en)
|
2009-12-04 |
2017-01-10 |
Сенхва Байосайенсиз, Инк. |
Pyrazolopyrimidines and related heterocycles as ck2 inhibitors
|
WO2011075613A1
(en)
|
2009-12-18 |
2011-06-23 |
Sanofi |
Azaindole derivatives, their preparation and their therapeutic application
|
US8680108B2
(en)
|
2009-12-18 |
2014-03-25 |
Incyte Corporation |
Substituted fused aryl and heteroaryl derivatives as PI3K inhibitors
|
WO2011075643A1
(en)
|
2009-12-18 |
2011-06-23 |
Incyte Corporation |
Substituted heteroaryl fused derivatives as pi3k inhibitors
|
CA2783575C
(en)
|
2009-12-23 |
2018-06-05 |
Jasco Pharmaceuticals, LLC |
Aminopyrimidine kinase inhibitors
|
GB201002861D0
(en)
|
2010-02-19 |
2010-04-07 |
Cxr Biosciences Ltd |
Compositions
|
CN102985417B
(en)
|
2010-03-10 |
2015-01-28 |
因塞特公司 |
Piperidin-4-yl azetidine derivatives as JAK1 inhibitors
|
PE20130405A1
(en)
*
|
2010-04-07 |
2013-04-10 |
Hoffmann La Roche |
PIRAZOL-4-IL-HETEROCICLIL-CARBOXAMIDE COMPOUNDS AND METHODS OF USE
|
US9193721B2
(en)
|
2010-04-14 |
2015-11-24 |
Incyte Holdings Corporation |
Fused derivatives as PI3Kδ inhibitors
|
US9062055B2
(en)
|
2010-06-21 |
2015-06-23 |
Incyte Corporation |
Fused pyrrole derivatives as PI3K inhibitors
|
JP2013530199A
(en)
|
2010-07-06 |
2013-07-25 |
ノバルティス アーゲー |
Cyclic ether compounds useful as kinase inhibitors
|
CN105367577B
(en)
*
|
2010-07-13 |
2019-04-23 |
弗·哈夫曼-拉罗切有限公司 |
Pyrazolo [1,5A] pyrimidine and thieno [3,2B] pyrimidine derivatives as IRAK4 regulator
|
US8227773B2
(en)
|
2010-07-29 |
2012-07-24 |
Axcelis Technologies, Inc. |
Versatile beam glitch detection system
|
US8791136B2
(en)
|
2010-07-29 |
2014-07-29 |
Rigel Pharmaceuticals, Inc. |
Substituted pyridine, pyridazine, pyrazine and pyrimidine compounds and methods for using the same
|
US8802099B2
(en)
|
2010-11-10 |
2014-08-12 |
National Jewish Health |
Methods to treat allergic conditions
|
WO2012065297A1
(en)
|
2010-11-16 |
2012-05-24 |
Impact Therapeutics, Inc. |
3-ARYL-6-ARYL-[1,2,4]TRIAZOLO[4,3-a]PYRIDINES AS INHIBITORS OF CELL PROLIFERATION AND THE USE THEREOF
|
EP2640725B1
(en)
|
2010-11-19 |
2015-01-07 |
Incyte Corporation |
Heterocyclic-substituted pyrrolopyridines and pyrrolopyrimidines as jak inhibitors
|
TW201249845A
(en)
|
2010-11-19 |
2012-12-16 |
Incyte Corp |
Cyclobutyl substituted pyrrolopyridine and pyrrolopyrimidine derivatives as JAK inhibitors
|
US9090593B2
(en)
|
2010-12-09 |
2015-07-28 |
Amgen Inc. |
Bicyclic compounds as Pim inhibitors
|
RU2652638C2
(en)
|
2010-12-17 |
2018-04-28 |
НЕРВИАНО МЕДИКАЛ САЙЕНСИЗ С.р.л. |
Substituted pyrazolo-quinazoline derivatives as kinase inhibitors
|
TW201249844A
(en)
|
2010-12-20 |
2012-12-16 |
Incyte Corp |
N-(1-(substituted-phenyl)ethyl)-9H-purin-6-amines as PI3K inhibitors
|
JP5925808B2
(en)
|
2011-01-26 |
2016-05-25 |
ネルビアーノ・メデイカル・サイエンシーズ・エツセ・エルレ・エルレ |
Tricyclic derivatives, their preparation and their use as kinase inhibitors
|
BR112013018515B1
(en)
|
2011-01-26 |
2021-06-29 |
Nerviano Medical Sciences S.R.I |
TRICYCLICAL PYRROL DERIVATIVES, PROCESS FOR THEIR PREPARATION AND USE AS KINASE INHIBITORS
|
JP6039585B2
(en)
|
2011-02-25 |
2016-12-07 |
アレイ バイオファーマ、インコーポレイテッド |
Triazolopyridine compounds as PIM kinase inhibitors
|
UY33930A
(en)
|
2011-03-04 |
2012-10-31 |
Novartis Ag |
NEW QUINASE INHIBITORS
|
WO2012120415A1
(en)
|
2011-03-04 |
2012-09-13 |
Novartis Ag |
Tetrasubstituted cyclohexyl compounds as kinase inhibitors
|
US9108984B2
(en)
|
2011-03-14 |
2015-08-18 |
Incyte Corporation |
Substituted diamino-pyrimidine and diamino-pyridine derivatives as PI3K inhibitors
|
CA2830780A1
(en)
|
2011-03-22 |
2012-09-27 |
Amgen Inc. |
Azole compounds as pim inhibitors
|
WO2012135009A1
(en)
|
2011-03-25 |
2012-10-04 |
Incyte Corporation |
Pyrimidine-4,6-diamine derivatives as pi3k inhibitors
|
MX2013011612A
(en)
|
2011-04-05 |
2013-10-17 |
Pfizer Ltd |
Pyrrolo [2, 3 -d] pyrimidine derivatives as inhibitors of tropomyosin- related kinases.
|
JP5976778B2
(en)
|
2011-04-11 |
2016-08-24 |
ネルビアーノ・メデイカル・サイエンシーズ・エツセ・エルレ・エルレ |
Pyrazolyl-pyrimidine derivatives as kinase inhibitors
|
CA2832865C
(en)
|
2011-04-22 |
2021-05-11 |
Jasco Pharmaceuticals, LLC |
Aminopyrimidine kinase inhibitors
|
GB201107176D0
(en)
|
2011-04-28 |
2011-06-15 |
Cxr Biosciences Ltd |
Pyrrolnitrin derivatives
|
GB201107197D0
(en)
|
2011-04-28 |
2011-06-15 |
Cxr Biosciences Ltd |
Compounds
|
CA2834166A1
(en)
|
2011-04-29 |
2012-11-01 |
Amgen Inc. |
Bicyclic pyridazine compounds as pim inhibitors
|
WO2012156367A1
(en)
|
2011-05-17 |
2012-11-22 |
Bayer Intellectual Property Gmbh |
Amino-substituted imidazopyridazines as mknk1 kinase inhibitors
|
BR112013029711B1
(en)
|
2011-05-19 |
2020-05-12 |
Fundación Centro Nacional De Investigaciones Oncológicas Carlos Iii |
COMPOUNDS
|
RU2013157898A
(en)
|
2011-05-27 |
2015-07-10 |
Темпл Юниверсити-Оф Дзе Коммонвелт Систем Оф Хайер Эдьюкейшн |
SUBSTITUTED 2-BENZYLIDENE-2H-BENZO [b] [1,4] THIAZIN-3 (4H) -OHES, THEIR DERIVATIVES AND THEIR APPLICATION FOR THERAPEUTIC PURPOSES
|
ES2625854T3
(en)
|
2011-06-01 |
2017-07-20 |
Bayer Intellectual Property Gmbh |
Aminoimidazopyridazines substituted
|
WO2012170827A2
(en)
|
2011-06-08 |
2012-12-13 |
Cylene Pharmaceuticals, Inc. |
Pyrazolopyrimidines and related heterocycles as ck2 inhibitors
|
WO2012177606A1
(en)
|
2011-06-20 |
2012-12-27 |
Incyte Corporation |
Azetidinyl phenyl, pyridyl or pyrazinyl carboxamide derivatives as jak inhibitors
|
CA2839958A1
(en)
|
2011-06-22 |
2012-12-27 |
Knut Eis |
Heterocyclyl aminoimidazopyridazines
|
PL3409278T3
(en)
|
2011-07-21 |
2021-02-22 |
Sumitomo Pharma Oncology, Inc. |
Heterocyclic protein kinase inhibitors
|
CN102924446B
(en)
|
2011-08-11 |
2015-08-26 |
上海吉铠医药科技有限公司 |
PIM kinase inhibitor and preparation method thereof and the application in pharmacy
|
KR20140071361A
(en)
|
2011-08-12 |
2014-06-11 |
에프. 호프만-라 로슈 아게 |
PYRAZOLO[3,4-c]PYRIDINE COMPOUNDS AND METHODS OF USE
|
TW201313721A
(en)
|
2011-08-18 |
2013-04-01 |
Incyte Corp |
Cyclohexyl azetidine derivatives as JAK inhibitors
|
KR101982475B1
(en)
|
2011-09-02 |
2019-05-27 |
인사이트 홀딩스 코포레이션 |
Heterocyclylamines as pi3k inhibitors
|
JP5843524B2
(en)
|
2011-09-02 |
2016-01-13 |
キヤノン株式会社 |
Organic-inorganic composite composition, organic-inorganic composite material, optical element and laminated diffractive optical element
|
UA117092C2
(en)
|
2011-09-06 |
2018-06-25 |
Байєр Інтеллектуал Проперті Гмбх |
Amino-substituted imidazopyridazines
|
UA111854C2
(en)
|
2011-09-07 |
2016-06-24 |
Інсайт Холдінгс Корпорейшн |
METHODS AND INTERMEDIATE COMPOUNDS FOR JAK INHIBITORS
|
JP6174586B2
(en)
|
2011-09-23 |
2017-08-02 |
バイエル・インテレクチュアル・プロパティ・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツングBayer Intellectual Property GmbH |
Substituted imidazopyridazine
|
AR088061A1
(en)
|
2011-09-27 |
2014-05-07 |
Hoffmann La Roche |
COMPOUNDS OF PIRAZOL-4-IL-HETEROCICLIL-CARBOXAMIDE AND METHODS OF USE
|
EP2788350B1
(en)
|
2011-10-07 |
2017-12-06 |
Nerviano Medical Sciences S.r.l. |
4-ALKYL SUBSTITUTED 3,4-DIHYDROPYRROLO[1,2-a]PYRAZIN-1(2H)-ONE DERIVATIVES AS KINASES INHIBITORS
|
ES2639064T3
(en)
|
2011-10-07 |
2017-10-25 |
Nerviano Medical Sciences S.R.L. |
3,4-Dihydropyrrolo [1,2-a] pyrazin-1 (2h) -one derivatives substituted as kinase inhibitors
|
ES2629690T3
(en)
|
2011-11-04 |
2017-08-14 |
Jasco Pharmaceuticals, LLC |
Aminopyrimidine Kinase Inhibitors
|
WO2013130660A1
(en)
|
2012-02-28 |
2013-09-06 |
Amgen Inc. |
Amides as pim inhibitors
|
EP2822944A1
(en)
|
2012-03-05 |
2015-01-14 |
Amgen, Inc. |
Oxazolidinone compounds and derivatives thereof
|
JP6173426B2
(en)
|
2012-03-29 |
2017-08-02 |
バイエル・インテレクチュアル・プロパティ・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツングBayer Intellectual Property GmbH |
Amino-substituted imidazopyridazine
|
AR090548A1
(en)
|
2012-04-02 |
2014-11-19 |
Incyte Corp |
BICYCLIC AZAHETEROCICLOBENCILAMINS AS PI3K INHIBITORS
|
CN104321326B
(en)
|
2012-04-04 |
2017-05-31 |
拜耳医药股份有限公司 |
The Imidazopyridazine of amino substitution
|
NZ631027A
(en)
|
2012-04-26 |
2016-03-31 |
Bristol Myers Squibb Co |
Imidazothiadiazole and imidazopyrazine derivatives as protease activated receptor 4 (par4) inhibitors for treating platelet aggregation
|
PE20150724A1
(en)
|
2012-04-27 |
2015-05-17 |
Novartis Ag |
BRIDGE HEAD CYCLIC ETHER DGAT1 INHIBITORS
|
IN2014DN09434A
(en)
|
2012-05-09 |
2015-07-17 |
Karyopharm Therapeutics Inc |
|
LT2861579T
(en)
|
2012-05-15 |
2018-05-10 |
Novartis Ag |
Benzamide derivatives for inhibiting the activity of abl1, abl2 and bcr-abl1
|
TW201406761A
(en)
|
2012-05-18 |
2014-02-16 |
Incyte Corp |
Piperidinylcyclobutyl substituted pyrrolopyridine and pyrrolopyrimidine derivatives as JAK inhibitors
|
AU2013264831B2
(en)
|
2012-05-21 |
2016-04-21 |
Novartis Ag |
Novel ring-substituted N-pyridinyl amides as kinase inhibitors
|
EP2852603B1
(en)
|
2012-05-22 |
2021-05-12 |
Idenix Pharmaceuticals LLC |
D-amino acid compounds for liver disease
|
TWI568722B
(en)
|
2012-06-15 |
2017-02-01 |
葛蘭馬克製藥公司 |
Triazolone compounds as mpges-1 inhibitors
|
RU2665462C2
(en)
|
2012-06-27 |
2018-08-30 |
Ф. Хоффманн-Ля Рош Аг |
5-azaindazole compounds and methods for use thereof
|
TW201408652A
(en)
|
2012-07-11 |
2014-03-01 |
Hoffmann La Roche |
Aryl sultam derivatives as RORc modulators
|
TW201414737A
(en)
|
2012-07-13 |
2014-04-16 |
必治妥美雅史谷比公司 |
Imidazotriazinecarbonitriles useful as kinase inhibitors
|
WO2014022752A1
(en)
|
2012-08-03 |
2014-02-06 |
Amgen Inc. |
Macrocycles as pim inhibitors
|
WO2014033631A1
(en)
|
2012-08-31 |
2014-03-06 |
Novartis Ag |
N-(3-pyridyl) biarylamides as kinase inhibitors
|
WO2014033630A1
(en)
|
2012-08-31 |
2014-03-06 |
Novartis Ag |
Novel aminothiazole carboxamides as kinase inhibitors
|
CN103664878A
(en)
|
2012-09-12 |
2014-03-26 |
山东亨利医药科技有限责任公司 |
Hetero-aromatic ring and derivative type tyrosine kinase inhibitor thereof
|
AR092568A1
(en)
|
2012-09-14 |
2015-04-22 |
Abbvie Deutschland |
TRICYCLE DERIVATIVES OF QUINOLINAS AND QUINOXALINAS
|
WO2014048939A1
(en)
|
2012-09-26 |
2014-04-03 |
F. Hoffmann-La Roche Ag |
Cyclic ether pyrazol-4-yl-heterocyclyl-carboxamide compounds and methods of use
|
WO2014053568A1
(en)
|
2012-10-02 |
2014-04-10 |
Sanofi |
Indolyldihydroimidazopyrimidinone derivatives, preparation thereof and therapeutic use thereof
|
PT2909195T
(en)
|
2012-10-16 |
2017-09-13 |
Janssen Sciences Ireland Uc |
Rsv antiviral compounds
|
MX2015005428A
(en)
|
2012-11-01 |
2015-07-21 |
Incyte Corp |
Tricyclic fused thiophene derivatives as jak inhibitors.
|
ES2646916T3
(en)
|
2012-11-19 |
2017-12-18 |
Bayer Pharma Aktiengesellschaft |
Aminoimidazopyridazines as inhibitors of MKNK1 kinase
|
WO2014079011A1
(en)
|
2012-11-22 |
2014-05-30 |
Agios Pharmaceuticals, Inc. |
Heterocyclic compounds for inhibiting glutaminase and their methods of use
|
SI3808749T1
(en)
*
|
2012-12-07 |
2023-07-31 |
Vertex Pharmaceuticals Incorporated |
Pyrazolo(1,5-a)pyrimidines useful as inhibitors of atr kinase for the treatment of cancer diseases
|
AU2013361602B2
(en)
|
2012-12-18 |
2018-02-01 |
Vertex Pharmaceuticals Incorporated |
Mannose derivatives for treating bacterial infections
|
WO2014097151A2
(en)
|
2012-12-19 |
2014-06-26 |
Novartis Ag |
Autotaxin inhibitors
|
US20150336960A1
(en)
|
2012-12-19 |
2015-11-26 |
Novartis Ag |
Aryl-substituted fused bicyclic pyridazine compounds
|
PL3067358T3
(en)
|
2012-12-21 |
2020-02-28 |
Gilead Sciences, Inc. |
Polycyclic-carbamoylpyridone compounds and their pharmaceutical use
|
JP6678455B2
(en)
|
2012-12-21 |
2020-04-08 |
エピザイム,インコーポレイティド |
PRMT5 inhibitors and uses thereof
|
FR3000569B1
(en)
|
2013-01-03 |
2015-02-13 |
Peugeot Citroen Automobiles Sa |
SCREEN LIGHTING DEVICE WITH LUMINOUS EDGE (S)
|
CA2897200C
(en)
|
2013-01-14 |
2021-07-06 |
Incyte Corporation |
Bicyclic aromatic carboxamide compounds useful as pim kinase inhibitors
|
US9200004B2
(en)
|
2013-01-15 |
2015-12-01 |
Incyte Holdings Corporation |
Thiazolecarboxamides and pyridinecarboxamide compounds useful as Pim kinase inhibitors
|
TWI657090B
(en)
|
2013-03-01 |
2019-04-21 |
英塞特控股公司 |
USE OF PYRAZOLOPYRIMIDINE DERIVATIVES FOR THE TREATMENT OF PI3Kδ RELATED DISORDERS
|
SI3489239T1
(en)
|
2013-03-06 |
2022-04-29 |
Incyte Holdings Corporation |
Processes and intermediates for making a jak inhibitor
|
JO3383B1
(en)
|
2013-03-14 |
2019-03-13 |
Lilly Co Eli |
CDC7 Inhibitors
|
UY35421A
(en)
|
2013-03-15 |
2014-10-31 |
Nihon Nohyaku Co Ltd |
CONDENSED HETEROCYCLIC COMPOUND OR ITS SALT, AGRICULTURAL OR HERITAGE INSECTICIDE THAT INCLUDES THE COMPOSITE AND METHOD OF USE OF THE INSECTICIDE
|
CA2902711C
(en)
|
2013-03-15 |
2021-07-06 |
Global Blood Therapeutics, Inc. |
Substituted pyridinyl-6-methoxy-2-hydroxybenzaldehyde derivatives and pharmaceutical compositions thereof useful for the modulation of hemoglobin
|
CA2900910C
(en)
|
2013-03-15 |
2021-03-30 |
Actelion Pharmaceuticals Ltd |
Pyridin-4-yl derivatives
|
KR20190041548A
(en)
|
2013-03-15 |
2019-04-22 |
글로벌 블러드 테라퓨틱스, 인크. |
Compounds and uses thereof for the modulation of hemoglobin
|
TWI689490B
(en)
|
2013-03-15 |
2020-04-01 |
英商邊緣生物科技有限公司 |
Substituted aromatic compounds and related method for the treatment of fibrosis
|
SI2975028T1
(en)
|
2013-03-15 |
2018-07-31 |
Japan Tobacco, Inc. |
Pyrazole-amide compound and medicinal uses therefor
|
AR095443A1
(en)
|
2013-03-15 |
2015-10-14 |
Fundación Centro Nac De Investig Oncológicas Carlos Iii |
HEREROCICLES CONDENSED WITH ACTION ON ATR
|
TW201522341A
(en)
|
2013-03-15 |
2015-06-16 |
Respivert Ltd |
Compound
|
NZ712453A
(en)
|
2013-03-15 |
2020-06-26 |
Incyte Holdings Corp |
Tricyclic heterocycles as bet protein inhibitors
|
TWI742541B
(en)
|
2013-03-15 |
2021-10-11 |
英商邊緣生物科技有限公司 |
Substituted aromatic compounds for the treatment of pulmonary fibrosis, liver fibrosis, skin fibrosis and cardiac fibrosis
|
KR20210125575A
(en)
|
2013-03-15 |
2021-10-18 |
코르테바 애그리사이언스 엘엘씨 |
4-amino-6-(heterocyclic)picolinates and 6-amino-2-(heterocyclic)pyrimidine-4-carboxylates and their use as herbicides
|
US20160052926A1
(en)
|
2013-03-15 |
2016-02-25 |
Hutchison Medipharma Limited |
Novel pyrimidine and pyridine compounds and usage thereof
|
US9308236B2
(en)
|
2013-03-15 |
2016-04-12 |
Bristol-Myers Squibb Company |
Macrocyclic inhibitors of the PD-1/PD-L1 and CD80(B7-1)/PD-L1 protein/protein interactions
|
KR102244719B1
(en)
|
2013-03-15 |
2021-04-26 |
플렉시콘 인코퍼레이티드 |
Heterocyclic compounds and uses thereof
|
US20140275108A1
(en)
|
2013-03-15 |
2014-09-18 |
Galderma Research & Development |
Novel benzenesulfonamide compounds, method for synthesizing same, and use thereof in medicine as well as in cosmetics
|
EA201690357A1
(en)
|
2013-08-07 |
2016-07-29 |
Инсайт Корпорейшн |
DOSAGE FORMS WITH Slow Release For JAK1 Inhibitor
|
SG11201601259YA
(en)
|
2013-08-23 |
2016-03-30 |
Incyte Corp |
Furo- and thieno-pyridine carboxamide compounds useful as pim kinase inhibitors
|
WO2015131031A1
(en)
|
2014-02-28 |
2015-09-03 |
Incyte Corporation |
Jak1 inhibitors for the treatment of myelodysplastic syndromes
|
MX2020004398A
(en)
|
2014-04-08 |
2022-06-06 |
Incyte Corp |
Treatment of b-cell malignancies by a combination jak and pi3k inhibitor.
|
MX2016014192A
(en)
|
2014-04-30 |
2017-05-01 |
Incyte Corp |
Processes of preparing a jak1 inhibitor and new forms thereto.
|
US9498467B2
(en)
|
2014-05-30 |
2016-11-22 |
Incyte Corporation |
Treatment of chronic neutrophilic leukemia (CNL) and atypical chronic myeloid leukemia (aCML) by inhibitors of JAK1
|
US10077277B2
(en)
|
2014-06-11 |
2018-09-18 |
Incyte Corporation |
Bicyclic heteroarylaminoalkyl phenyl derivatives as PI3K inhibitors
|
US9580418B2
(en)
|
2014-07-14 |
2017-02-28 |
Incyte Corporation |
Bicyclic aromatic carboxamide compounds useful as Pim kinase inhibitors
|
US9822124B2
(en)
|
2014-07-14 |
2017-11-21 |
Incyte Corporation |
Bicyclic heteroaromatic carboxamide compounds useful as Pim kinase inhibitors
|
WO2016196244A1
(en)
|
2015-05-29 |
2016-12-08 |
Incyte Corporation |
Pyridineamine compounds useful as pim kinase inhibitors
|
TWI734699B
(en)
|
2015-09-09 |
2021-08-01 |
美商英塞特公司 |
Salts of a pim kinase inhibitor
|
US9920032B2
(en)
|
2015-10-02 |
2018-03-20 |
Incyte Corporation |
Heterocyclic compounds useful as pim kinase inhibitors
|